Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease
Cells · 22.03.2023 · 12 (6) · 962
DOI: 10.3390/cells12060962 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 22.03.2023. Verfasst von Antía Custodia und 10 weiteren Autor:innen. Beteiligte Einrichtung: NeuroAging Group (NEURAL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), 15706 Santi…. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognition Disorders, Vascular Diseases. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xunta de Galicia, Ministry of Science and Innovation, Institute of Health Carlos III.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most common degenerative disorder in the elderly in developed countries. Currently, growing evidence is pointing at endothelial dysfunction as a key player in the cognitive decline course of AD. As a main component of the blood–brain barrier (BBB), the dysfunction of endothelial cells driven by vascular risk factors associated with AD allows the passage of toxic substances to the cerebral parenchyma, producing chronic hypoperfusion that eventually causes an inflammatory and neurotoxic response. In this process, the levels of several biomarkers are disrupted, such as an increase in adhesion molecules that allow the passage of leukocytes to the cerebral parenchyma, increasing the permeability of the BBB; moreover, other vascular players, including endothelin-1, also mediate artery inflammation. As a consequence of the disruption of the BBB, a progressive neuroinflammatory response is produced that, added to the astrogliosis, eventually triggers neuronal degeneration (possibly responsible for cognitive deterioration). Recently, new molecules have been proposed as early biomarkers for endothelial dysfunction that can constitute new therapeutic targets as well as early diagnostic and prognostic markers for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NeuroAging Group (NEURAL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
- Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Neuroimaging and Biotechnology Laboratory (NOBEL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
ORCID-Profile: Antía Custodia, Marta Aramburu-Núñez, Alberto Ouro, Tomás Sobrino, Daniel Romaus-Sanjurjo
Förderung
- Xunta de Galicia
- Ministry of Science and Innovation
- Institute of Health Carlos III
- CIBER -Consorcio Centro de Investigación Biomédica en Red- Enfermedades Neurodegnerativas (CIBERNED)
- INTERREG Atlantic Area
- INTER-REG V A España Portugal (POCTEP)
- European Commission under the PANA project
- Miguel Servet Program from ISCIII
Zitieren
APA
Custodia, A., Aramburu-Núñez, M., Rodríguez-Arrizabalaga, M., Pías-Peleteiro, J. M., Vázquez-Vázquez, L., Camino-Castiñeiras, J., Aldrey, J. M., Castillo, J., Ouro, A., Sobrino, T., & Romaus-Sanjurjo, D. (2023). Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease. Cells, 12(6), 962. https://doi.org/10.3390/cells12060962
Vancouver
Custodia A, Aramburu-Núñez M, Rodríguez-Arrizabalaga M, Pías-Peleteiro JM, Vázquez-Vázquez L, Camino-Castiñeiras J, et al. Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease. Cells. 2023;12(6):962. doi:10.3390/cells12060962
BibTeX
@article{Custodia2023,
author = {Custodia, Antía and Aramburu-Núñez, Marta and Rodríguez-Arrizabalaga, Mariña and Pías-Peleteiro, Juan Manuel and Vázquez-Vázquez, Laura and Camino-Castiñeiras, Javier and Aldrey, José Manuel and Castillo, José and Ouro, Alberto and Sobrino, Tomás and Romaus-Sanjurjo, Daniel},
title = {Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease},
journal = {Cells},
year = {2023},
volume = {12},
number = {6},
pages = {962},
doi = {10.3390/cells12060962}
}
EUVIMED